← Medpace Holdings, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income (Loss) Attributable to Parent | $13.4m | $39.1m | $73.2m | $100.4m | $145.4m | $181.8m | $245.4m | $282.8m | $404.4m | $451.1m | |
| Net Income (Loss) Available to Common Stockholders, Basic | $13.4m | $39.0m | $72.9m | $100.2m | $144.9m | $181.4m | $245.2m | $282.6m | $404.3m | $451.1m | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | — | $73.2m | $100.4m | $145.4m | $181.8m | $245.4m | — | — | — | |
| Amortization of Debt Issuance Costs and Discounts | $2.6m | $662k | $615k | $954k | $0 | $0 | — | — | — | — | |
| Amortization of Intangible Assets | $50.7m | $37.9m | $29.6m | $14.8m | $7.9m | $5.1m | $3.4m | $2.2m | $1.4m | $946k | |
| Depreciation | $7.4m | $8.6m | $9.2m | $8.4m | $11.7m | $16.0m | $19.0m | $24.1m | $27.8m | $27.2m | |
| Deferred Income Tax Expense (Benefit) | ($9.0m) | $3.2m | $3.9m | $10.1m | $527k | ($37.1m) | ($23.0m) | ($25.1m) | ($26.6m) | $80.9m | |
| Share-based Payment Arrangement, Noncash Expense | $9.8m | $4.5m | $6.5m | $20.7m | $13.8m | $14.5m | $21.4m | $20.5m | $25.5m | $34.8m | |
| Share-based Payment Arrangement, Expense | $9.8m | — | — | — | — | — | — | — | — | — | |
| Goodwill, Impairment Loss | $0 | $0 | — | — | — | — | — | — | — | — | |
| Gain (Loss) on Extinguishment of Debt | ($10.7m) | $0 | $0 | — | — | — | — | — | — | — | |
| Income Tax Expense (Benefit) | $8.5m | $17.8m | $20.8m | $24.4m | $23.1m | $20.0m | $37.5m | $52.9m | $71.5m | $91.3m | |
| Other Nonoperating Income (Expense) | ($423k) | ($354k) | $1.1m | ($863k) | $1.2m | $3.3m | $7.1m | ($655k) | $4.1m | ($5.3m) | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Payable | $691k | $4.8m | $1.3m | $4.7m | ($2.6m) | $1.9m | $6.4m | $1.1m | ($3.0m) | $2.6m | |
| Foreign Currency Transaction Gain (Loss), Realized | ($660k) | ($1.0m) | $386k | ($581k) | $514k | $2.8m | $3.9m | ($1.9m) | ($496k) | ($7.7m) | |
| Goodwill | $661.0m | $661.0m | $661.0m | $662.4m | $662.4m | $662.4m | $662.4m | $662.4m | $662.4m | $662.4m | |
| Nonoperating Income (Expense) | ($30.5m) | ($7.9m) | ($7.1m) | ($2.4m) | $1.5m | $3.2m | $4.2m | ($1.1m) | $29.1m | $7.4m | |
| Proceeds from Stock Options Exercised | $537k | $1.8m | $2.5m | $6.5m | $16.0m | $17.6m | $22.1m | $11.4m | $15.9m | $57.0m | |
| Net Cash Provided by (Used in) Operating Activities | $91.7m | $97.4m | $156.6m | $201.9m | $258.7m | $263.3m | $388.1m | $433.4m | $608.8m | $713.2m | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $13.5m | $11.7m | $16.0m | $17.9m | $31.3m | $28.3m | $36.9m | $36.6m | $36.5m | $31.4m | |
| Payments for (Proceeds from) Other Investing Activities | ($115k) | ($56k) | $949k | $1.2m | ($126k) | $3.1m | $1.9m | ($2.0m) | ($8.2m) | ($216k) | |
| Net Cash Provided by (Used in) Investing Activities | ($13.4m) | ($12.2m) | ($17.0m) | ($19.1m) | ($31.2m) | ($31.4m) | ($38.7m) | ($34.6m) | ($28.3m) | ($31.1m) | |
| Cash flows from financing activities: | |||||||||||
| Proceeds from Issuance of Common Stock | $173.6m | $0 | $0 | — | — | — | — | — | — | — | |
| Payments for Repurchase of Common Stock | — | $155.6m | $0 | $0 | $98.3m | $62.1m | $847.8m | $144.0m | $169.9m | $917.4m | |
| Net Cash Provided by (Used in) Financing Activities | ($58.0m) | ($97.8m) | ($141.6m) | ($73.9m) | ($82.3m) | ($44.5m) | ($775.8m) | ($182.6m) | ($154.0m) | ($860.4m) | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | ($632k) | $1.8m | ($1.2m) | ($167k) | $666k | ($4.0m) | ($6.6m) | $1.1m | ($2.5m) | $5.9m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | ($632k) | ($10.9m) | ($3.2m) | $108.6m | $145.8m | $183.5m | ($433.0m) | $217.2m | $424.0m | ($172.4m) | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | ($632k) | $26.5m | $23.3m | $131.9m | $277.8m | $461.3m | $28.3m | $245.4m | $669.4m | $497.0m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $16.9m | $6.9m | $7.6m | $1.5m | $104k | $123k | $2.9m | $3.1m | $171k | $0 | |
| Income Taxes Paid, Net | $17.7m | $17.2m | $23.3m | $13.2m | $23.1m | $56.2m | $50.2m | $76.4m | $83.6m | $39.7m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.